From Tissue Specificity to Systemic Cues: Shaping MYC-Driven Tumor Metabolism.

MYC drives tissue-specific and systemic metabolic reprogramming in tumors, creating context-dependent vulnerabilities that can be targeted for therapy.

• Why it matters: Understanding how MYC influences tumor metabolism across different tissues and systemic factors is crucial for developing precise treatments for MYC-driven cancers, which vary widely in their metabolic dependencies.
• What they did: The review examines in vivo metabolic programs activated by MYC, highlighting the roles of tissue context, tumor microenvironment, and systemic influences like diet, based on current research and metabolic interactions.
• The result: These insights reveal potential metabolic vulnerabilities unique to MYC-driven tumors, paving the way for targeted therapies that exploit these context-specific dependencies.